Investing

Technical Analysis Explained

Technical Analysis Explained

Technical Analysis (TA) is a trading methodology that allows you to evaluate the investments by analyzing statistical trends in the stock market.

It is applied to indices, stocks, commodities or any tradable items where price is changed by supply and demand forces.

Assumptions in Technical Analysis

Technical analysis is based on some key assumptions. To get the best results, one needs to be aware of these assumptions.

  • Price moves in trend

Market trend is the foundation of technical analysis. All major changes, one observes in stock market, is the outcome of a trend. Once the trend is set, the price of stocks moves in the direction of the trend.

  • Market discount everything

According to this assumption, the latest stock price reflects all known and unknown public domain information.

  • History tends to repeat itself

In the context of technical analysis, the price trend tends to repeat itself. It happens because investors consistently respond to price fluctuation at the same time, whenever the price fluctuates in a certain direction.

Steps for Technical Evaluation

Technical analysis mainly involves 3 steps for the evaluation purpose. These steps are:

  • Market analysis on broad level through major indices like NASDAQ, NYSE Composite and Dow Industrials.

  • Sector analysis in which the strongest and weakest groups are identified within the broader market.

  • Individual analysis in which the strongest and weakest stocks are identified within selected groups.

Technical analysis is very much versatile. Its principles are universally accepted and applicable, each of the technical analysis steps above can be performed with the same theoretical background. There is no need for an economics degree for the evaluation of a market index chart.

Volumes in Technical Analysis

Volume helps in confirming trends and patterns in technical analysis, hence play a very integral role. Volume is considered as a means to gain information about participants’ market perceptiveness.

It indicates number of shares bought and sold over a specific time period. Volume is directly related to active shares. More active shares mean higher volume. The presence of smart money is indicated by higher volumes while low volumes indicate retain participation. It is advised to avoid trading on low volume days.

The Dow Theory

Explanation of technical analysis is incomplete if the Dow Theory is not discussed in it. The Dow Theory is an integral part of technical analysis.

This theory was given by Charles H. Dow, who was also the founder of Dow-Jones financial new services (Wall Street Journal). ‘The Dow Theory’ is a series of articles written by him during the 1900s. William P Hamilton compiled these articles with relevant examples over a period of 27 years and produced it as ‘The Dow Theory’.

Principles of the Dow Theory

The principles or beliefs of the Dow Theory are called the Dow Theory tenets. These tenets are considered as the guiding force behind the Dow Theory.

  • Indices discounts everything.

  • Overall there are 3 broad market trends- Primary Trend, Secondary Trend and Minor Trend.

  • All indices must confirm each other.

  • Volumes must confirm.

  • Sideway markets can substitute secondary markets.

  • The closing price is the most scared.

Technical Indicators

Technical indicators mainly determine the market direction, up and down. However, there is another set of technical indicators whose prime function is not mainly to determine market direction. These indicators determine market strength. The popular tools included in these indicators are the Moving Average Convergence-Divergence (MACD) indicator, Stochastic Oscillator, the Relative Strength Index (RSI) and the Average Directional Movement Index (ADX).

Movement indicators measure the strength of price movement and help investors to determine whether current price movement is representing relatively insignificant trading or an actual, significant trend. Momentum indicators measure trend strength and can give early warning signals that a trend is coming to an end.

The Bottom Line

According to technical analysts, the market is 80% psychological and 20% logical. The fact that needs to be kept in mind is that no technical indicator is perfect. There is not a single indicator present which can be a signal that is 100%, accurate all the time.

Your profitability as a trader will certainly increase if technical analysis is done well. However, you may improve your fortunes in trading by spending more time and effort on doing those things which can help you in handling things when the market turns against you, rather than just dreaming about millions of dollars and how you are going to spend that money. Always remember, dreams don’t work unless you do. So, start your hustle to achieve your goals.

 

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Top 10 Most Recent News Articles

LIV Golf's Big Play: Restructuring with Saudi PIF

Updated Category News Views 6

Trailblazing Change in the Golf World It's like watching a high-stakes game of chess where pieces are worth billions. White Knight Capital Corp. has thrown its hat into the ring with the Public Investment Fund of Saudi Arabia to overhaul LIV Golf Enterprises. This isn't your average Monday morning golf chat; it's full-on corporate drama with financial steroids. Debt Swap...

Continue Reading
Innovative SOV Launches for Offshore Wind Revolution

Updated Category News Views 2

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

Continue Reading
MiniTool MovieMaker 8.9: Keyframe Animation Upgrade

Updated Category News Views 2

Breaking Down MiniTool MovieMaker 8.9's Revamp Kicking off the day with some noteworthy news in the creative software arena, MiniTool's latest update to its MovieMaker program is grabbing attention. It’s not often you hear software developers hitting the right balance between functionality and simplicity as they've done with this release. Keyframe Animation: The Star of...

Continue Reading
Fujifilm's New 400mm Lens: A Game Changer?

Updated Category News Views 1

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 2

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Potomac Edison Eyes Rate Hike for System Overhaul

Updated Category News Views 0

FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...

Continue Reading
Pathlock Faces Identity Governance Opportunities in 2026

Updated Category News Views 3

Challenges in Identity Governance Emerge for 2026 Imagine a world where digital identities run wild—unmonitored, orphaned, dormant. Welcome to 2026, where identity governance and administration (IGA) face a reckoning, dragging enterprises into the spotlight as they scramble to protect against identity chaos. With Pathlock’s recent recognition in the Gartner Market...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 6

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
China's Diplomatic Dance: SCO Summit & Key Visits

Updated Category News Views 2

A Diplomatic Balancing Act Xi Jinping's recent diplomatic tour, climaxing at the Shanghai Cooperation Organization (SCO) Summit and extending through critical visits to Kyrgyzstan and Egypt, paints a compelling picture of China's strategic intentions. For those of us watching the geopolitical chessboard, it's like seeing a master strategist at work—pondering a tricky...

Continue Reading

Top 5 Most Recently Viewed Articles

Theravance Buyout Scrutinized: Is Zymeworks Deal Fair?

Updated Category News Views 6

Theravance and Zymeworks: What's the Deal? First things first, the numbers. Theravance Biopharma, the biotech entity waving its NASDAQ: TBPH ticker, is about to jump into bed with Zymeworks, another player in the pharma game. The pitch? One hundred seventy-six bucks a share in cold, hard cash, plus a contingent value right. That's right—sweet on paper, but always worth...

Continue Reading
Top Stock Split Opportunities for Maximum Growth Potential

Updated Category News Views 72

Stock splits surged back into the limelight recently, flipping the script on a strategy that had been gathering dust. Once thought outdated, these moves have become hot again, reflecting how companies with robust performances can maintain investor interest while managing share prices effectively. When you see a stock split, it’s often more than just a number game; it's...

Continue Reading
Roc Nation and Musicow: Pioneering a New Era in Music Equity

Updated Category News Views 455

Roc Nation Collaborates with Musicow for Music Equity Innovation Roc Nation has embarked on an exciting partnership with Musicow, a South Korean fintech firm. This collaboration aims to introduce the first Music Equity Service Provider (MESP) in the United States. By allowing music rights holders to buy, sell, and trade shares in music royalty revenue, this initiative...

Continue Reading
Latest Updates from the FDA: New Guidelines and Approvals

Updated Category News Views 396

Insights from Recent FDA Activities The U.S. Food and Drug Administration (FDA) has released an overview of recent important developments aimed at enhancing public health and safety. These updates offer invaluable information about various health issues, product approvals, and guidance to manufacturers. Investigation of E. coli Outbreak Recently, the FDA updated its...

Continue Reading
Insider Sale Sparks Interest in BorgWarner's Future Prospects

Updated Category News Views 173

Understanding Insider Transactions at BorgWarner Recently, a notable insider sale captured attention. Isabelle McKenzie, the Vice President of BorgWarner, made headlines when she sold 2,500 shares, totaling around $100,025. This transaction was officially reported in a filing to the SEC, particularly through a Form 4. Such insider activities often spark curiosity among...

Continue Reading